ARCHIVES

In Brief: NCI Claim “Major Finding” In Treatment Of Soft Tissue Sarcoma With Three Modalities; 93% Survival

This article is from The Cancer Letter archive.

Vol. 07 No. 41 | October 9, 1981

Download PDF Visit The Full Archive

Related Articles

ECG Disputes Accrual Figures Cited By DeVita, Says Numbers Are Up 17% This Year And Still Rising

July 8, 1988

NCI Study Tests Method For Biomarker Validation

July 24, 2009

EPO Controversy: ODAC To Review EPO Agents in May; SEC Probes Amgen’s Delay in Study Disclosure.

March 2, 2007

Bypass Budget For FY 1992 Shown In Chart

May 18, 1990

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

October 14, 1994

NCI Grants Payline Could Reach 175 Under Final Fiscal 1985 Awards Level Of Approximately 1,000

August 9, 1985